Issue 1/2017
Content (24 Articles)
A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI
Andy Wolff, Revan Kumar Joshi, Jörgen Ekström, Doron Aframian, Anne Marie Lynge Pedersen, Gordon Proctor, Nagamani Narayana, Alessandro Villa, Ying Wai Sia, Ardita Aliko, Richard McGowan, Alexander Ross Kerr, Siri Beier Jensen, Arjan Vissink, Colin Dawes
Efficacy of Immunobiologic and Small Molecule Inhibitor Drugs for Psoriasis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
André Vicente Esteves de Carvalho, Rodrigo Pereira Duquia, Bernardo Lessa Horta, Renan Rangel Bonamigo
Salvia (Sage): A Review of its Potential Cognitive-Enhancing and Protective Effects
Adrian L. Lopresti
Vorapaxar: The Current Role and Future Directions of a Novel Protease-Activated Receptor Antagonist for Risk Reduction in Atherosclerotic Disease
Rebecca J. Gryka, Leo F. Buckley, Sarah M. Anderson
A Review of Clinical Outcomes Associated with Two Meropenem Dosing Strategies
Kyle John Wilby, Ziad Ghantous Nasr, Shereen Elazzazy, Tim T. Y. Lau, Anas Hamad
Drug Exposure and the Risk of Microscopic Colitis: A Critical Update
Alfredo J. Lucendo
Antithyroid Drug-Induced Agranulocytosis: State of the Art on Diagnosis and Management
Nuno Vicente, Luís Cardoso, Luísa Barros, Francisco Carrilho
Clinical Effects of Topiroxostat on Renal and Endothelial Function in A Patient with Chronic Kidney Disease and Hyperuricemic Arteriolopathy: A Case Report
Atsushi Tanaka, Tsukasa Nakamura, Eiichi Sato, Koichi Node
Retrospective Study of Patients Switched from Tablet Formulations to a Gel Cap Formulation of Levothyroxine: Results of the CONTROL Switch Study
Frank R. Ernst, Walter Sandulli, Riad Elmor, Jennifer Welstead, Arnold B. Sterman, MaryKate Lavan
Tolerability of Capecitabine Monotherapy in Metastatic Colorectal Cancer: A Real-World Study
Laura W. Leicher, Jacques C. de Graaf, Wilko Coers, Metin Tascilar, Jan Willem B. de Groot
Baseline Characteristics and Changes in Bone Mineral Density T-Scores of Bulgarian Women with Postmenopausal Osteoporosis Receiving Denosumab in Routine Clinical Practice
Mihail Boyanov, Alexander Shinkov, Emi Psachoulia, Michele Intorcia, Reneta Petkova
Safety Profile Based on Concordance of Nonclinical Toxicity and Clinical Adverse Drug Reactions for Blood Cancer Drugs Approved in Japan
Sachie Kubota, Kazuyuki Saito, Shunsuke Ono, Yasuo Kodama
Population Pharmacokinetics and Pharmacodynamics Modelling of Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome
Shuying Yang, Teodora Pene Dumitrescu
Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Model
Steven M. Brunelli, Scott P. Sibbel, David Van Wyck, Amit Sharma, Andrew Hsieh, Glenn M. Chertow
Besifloxacin Ophthalmic Suspension 0.6% Compared with Gatifloxacin Ophthalmic Solution 0.3% for the Treatment of Bacterial Conjunctivitis in Neonates
Christine M. Sanfilippo, Catherine M. Allaire, Heleen H. DeCory
Evaluation of Amikacin Pharmacokinetics and Pharmacodynamics for Optimal Initial Dosing Regimen
Hideo Kato, Mao Hagihara, Jun Hirai, Daisuke Sakanashi, Hiroyuki Suematsu, Naoya Nishiyama, Yusuke Koizumi, Yuka Yamagishi, Katsuhiko Matsuura, Hiroshige Mikamo
Rosiglitazone Metabolism in Human Liver Microsomes Using a Substrate Depletion Method
Maryam Bazargan, David J. R. Foster, Andrew K. Davey, Beverly S. Muhlhausler
Identification of a Syndrome Class of Neuropsychiatric Adverse Reactions to Mefloquine from Latent Class Modeling of FDA Adverse Event Reporting System Data
Remington L. Nevin, Jeannie-Marie Leoutsakos
Hepatotoxicity with Vismodegib: An MD Anderson Cancer Center and Research on Adverse Drug Events and Reports Project
Beatrice J. Edwards, Dennis W. Raisch, Smita S. Saraykar, Ming Sun, Josh A. Hammel, Hai T. Tran, Nathaniel Wehr, Rasha Arabyat, Dennis P. West
Saliva Versus Plasma Bioequivalence of Azithromycin in Humans: Validation of Class I Drugs of the Salivary Excretion Classification System
Nasir Idkaidek, Tawfiq Arafat, Hazim Hamadi, Salim Hamadi, Ibrahim Al-Adham
Effectiveness and Risk Factors for Virological Outcome of Raltegravir-Based Therapy for Treatment-Experienced HIV-Infected Patients
José Antonio Mata-Marín, Ariane Estrella Weiser Smeke, Mariana Rotzinger Rodriguez, Marcelino Chávez-García, Marco Isaac Banda-Lara, Alma Minerva Pérez Rios, Nohemí Nuñez-Rodríguez, Juan Carlos Domínguez-Hermosillo, Alberto Chaparro Sánchez, Irene Juarez-Kasusky, Javier Enrique Cruz Herrera, Jorge Luis Sandoval Ramírez, Jesús Gaytán-Martínez
Efficacy of Switching from Infliximab to Subcutaneous Golimumab in Patients with Rheumatoid Arthritis to Control Disease Activity or Adverse Events
Hiroki Wakabayashi, Hitoshi Inada, Yosuke Nishioka, Masahiro Hasegawa, Kusuki Nishioka, Akihiro Sudo
Comment on: “A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-aspartate Angiotensin I in Healthy Subjects”
Nuggehally R. Srinivas
Author’s Reply to Srinivas: “A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-Aspartate Angiotensin I in Healthy Subjects”
Meng-Kwoon Sim, Kok-Onn Lee